2026江苏两会 | 陈芸委员：强化创新医药出海知识产权主权，保障生物安全与产业核心竞争力

Core Viewpoint - Intellectual property has become a critical strategic resource for countries amid the accelerated restructuring of the global pharmaceutical supply chain and increasing technological competition [1] Group 1: Importance of Intellectual Property in Pharmaceuticals - The pharmaceutical industry in China is at a crucial stage of innovation transformation and international expansion [1] - Strengthening sovereignty over intellectual property in the pharmaceutical sector is vital for balancing development and security, promoting high-level technological self-reliance, ensuring public health, and safeguarding national long-term interests [4] Group 2: Recommendations for Intellectual Property Sovereignty Strategy - A proposal has been made to implement a pharmaceutical intellectual property sovereignty strategy, emphasizing top-level design and coordination [4] - Key areas, core objectives, and strategic paths for maintaining intellectual property sovereignty should be integrated into the overall layout of biological safety and technological innovation [4] - Establishing a provincial risk review and early warning mechanism for pharmaceutical intellectual property sovereignty is recommended, involving regular collaboration among intellectual property, drug regulation, technology, and commerce departments [4] Group 3: Legal and Regulatory Enhancements - There is a need to improve laws and regulations to strengthen the "firewall" of sovereignty, including clarifying core pharmaceutical technology export control lists and cross-border data flow safety management in relevant laws [4] - The proposal includes setting baseline requirements for the ownership of intellectual property in collaborative research outcomes [4] Group 4: International Standards Participation - Support for enterprises or institutions to lead or participate in the formulation of international standards, particularly in new therapies and digital healthcare, is suggested [5] - The aim is to incorporate independent intellectual property technologies into international standard systems to enhance China's substantive participation in rule-making [5]